Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy

NCT02072408 Phase 4 COMPLETED

The purpose of this study is to evaluate the efficacy and safety of aflibercept for treatment of polypoidal choroidal vasculopathy without active polyp.

Details

Lead sponsor	Samsung Medical Center
Phase	Phase 4
Status	COMPLETED
Enrolment	46
Start date	2014-02
Completion	2017-11-02

Conditions

• Polypoidal Choroidal Vasculopathy Without Active Polyp

Interventions

• aflibercept

Primary outcomes

• Change of best-corrected visual acuity (ETDRS letters) — 1 year

Countries

South Korea